NORA BREEN: Open Payments
NPI 1184893067 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 17 payments from 8 companies in 2025. Trend: 2023 $201 · 2024 $200 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 4 | $104 |
| Exeltis, USA Inc. | 4 | $98 |
| Astellas Pharma US Inc | 2 | $44 |
| MILLICENT US INC | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Novo Nordisk Inc | 1 | $23 |
| Organon LLC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: ZURZUVAE, SLYND, Veozah, FEMLYV, Wegovy, Mirena, Kyleena, NEXPLANON.
Industry payments across NY — which companies pay providers there.
